180 related articles for article (PubMed ID: 7056278)
1. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
Larsson R; Erlanson P; Bodemar G; Norlander B; Fransson L; Strouth L
Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
[TBL] [Abstract][Full Text] [Related]
3. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
[TBL] [Abstract][Full Text] [Related]
4. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
Larsson R; Norlander B; Bodemar G; Walan A
Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
[TBL] [Abstract][Full Text] [Related]
6. Oral absorption of cimetidine and its clearance in patients with renal failure.
Larsson R; Bodemar G; Norlander B
Eur J Clin Pharmacol; 1979 Apr; 15(3):153-7. PubMed ID: 456399
[TBL] [Abstract][Full Text] [Related]
7. Altered disposition and availability of cimetidine in liver cirrhotic patients.
Gugler R; Müller-Liebenau B; Somogyi A
Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
[TBL] [Abstract][Full Text] [Related]
8. Cimetidine clearance during intermittent and chronic peritoneal dialysis.
Hyneck ML; Murphy JF; Lipschutz DE
Am J Hosp Pharm; 1981 Nov; 38(11):1760-2. PubMed ID: 7304634
[TBL] [Abstract][Full Text] [Related]
9. Influence of phenobarbital treatment on cimetidine kinetics.
Somogyi A; Thielscher S; Gugler R
Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562
[TBL] [Abstract][Full Text] [Related]
10. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
Pizzella KM; Moore MC; Schultz RW; Walshe J; Schentag JJ
Ther Drug Monit; 1980; 2(3):273-81. PubMed ID: 7222181
[TBL] [Abstract][Full Text] [Related]
11. Rebound following hemodialysis of cimetidine and its metabolites.
Ziemniak JA; Cersosimo RJ; Russo J; Moran DM; Kablitz C; Schentag JJ
Am J Kidney Dis; 1984 May; 3(6):430-5. PubMed ID: 6720687
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
Kliem V; Bahlmann J; Hartmann M; Huber R; Lühmann R; Wurst W
Nephrol Dial Transplant; 1998 May; 13(5):1189-93. PubMed ID: 9623552
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of guanfacine in patients undergoing haemodialysis.
Kirch W; Kohler H; Axthelm T
Eur J Drug Metab Pharmacokinet; 1982; 7(4):277-80. PubMed ID: 6762301
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
Kogan FJ; Sampliner RE; Mayersohn M; Kazama RM; Perrier D; Jones W; Michael UF
J Clin Pharmacol; 1983; 23(5-6):252-6. PubMed ID: 6875024
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent pharmacokinetics of cimetidine in the rat.
Adedoyin A; Aarons L; Houston JB
Xenobiotica; 1987 May; 17(5):595-604. PubMed ID: 3604263
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
Bodemar G; Norlander B; Walan A
Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
[TBL] [Abstract][Full Text] [Related]
17. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
[TBL] [Abstract][Full Text] [Related]
18. Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis.
Spigset O; Hägg S; Stegmayr B; Dahlqvist R
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):699-703. PubMed ID: 11214779
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic renal failure on the pharmacokinetics of ruboxistaurin and its active metabolite 338522.
Wise S; Yuen E; Chan C; Poo YK; Teng L; Lau T; Voelker J
Clin Pharmacokinet; 2006; 45(3):297-303. PubMed ID: 16509761
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal dialysis clearance of cimetidine.
Vaziri ND; Ness RL; Barton CH
Am J Gastroenterol; 1979 Jun; 71(6):572-6. PubMed ID: 313152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
